Evidence map›Paper›PMID 31186809›Full record

ArticleOncology letters2019

High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.

Gaoqi Zhang, Jinlong Shi, Xinrui Yang, Xinpei Zhang, Lingxiu Zhang, Jilei Zhang, Siyuan Yang, Jing Wang, Kai Hu, Xiaoyan Ke and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gaoqi ZhangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, P.R. China.
Jinlong ShiDepartment of Biomedical Engineering, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China.
Xinrui YangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, P.R. China.
Xinpei ZhangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, P.R. China.
Lingxiu ZhangDepartment of Hematology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.
Jilei ZhangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, P.R. China.
Siyuan YangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, P.R. China.
Jing WangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, P.R. China.
Kai HuDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, P.R. China.
Xiaoyan KeDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, P.R. China.
Lin FuDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNA-500 (miR-500) is a potential prognostic biomarker in a number of different types of cancer, such as prostate cancer and hepatocellular carcinoma. This study aimed to explore the clinical implications of miR-500 expression status in patients with acute myeloid leukemia (AML) that had received allogeneic hematopoietic stem cell transplantation (allo-HSCT). miR-500 expression status and clinical data were obtained from 74 patients with AML in the The Cancer Genome Atlas database receiving allo-HSCT. Patients with low expression level of miR-500 (miR-500

Indexed as

acute myeloid leukemiaallogeneic hematopoietic stem cell transplantationmicroRNA-500prognosis

Identifiers

PMID31186809
PMCPMC6507407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.